Investors are likely to zero in on share repurchases after Berkshire resumed buybacks in March for the first time since 2024.
Source: US Top News and Analysis
Related Posts
This pharmaceutical stock is cheap relative to peers. UBS thinks it’s due for a bounce
The investment bank upgraded the pharmaceutical name to buy from neutral. Source: US Top News…
Goldman Sachs is set to report first-quarter earnings — here’s what Wall Street expects
Trading desks across Wall Street have been busy at the start of the year as…
NAACP sues Elon Musk’s xAI over Memphis data center air pollution
Elopn Musk, who is the world’s richest person, has been counting on the greater Memphis…